1[1]Seli E,Berkkanoglu M,Arici A.Pathogenesis of endometriosis[J].Obstet Gynecol Clin North Am,2003,30(1):41-61.
2[2]Chung HW.Matrix metalloproteinase-2,membranous type 1 matrix metalloproteinase,and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium[J].Fertil Steril,2002,78(4):787-795.
3[3]Chung HW,Wen Y,Chun SH,et al.Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis:a rationale for endometriotic invasiveness[J].Fertil Steril,2001,75(1):152-159.
5[5]Rigot V,Marbaix E,Lemoine P,et al.In vivo perimenstrual activation of progelatinase B(proMMP-9) in the human endometrium and its dependence on stromelysin 1(MMP-3) ex vivo[J].Biochem J,2001,358(Pt 1):275-280.
6[6]Thomas E,Curry Jr,Kevin G,et al.Cyclic changes in the matrix metalloproteinase system in the ovary and uterus[J].Biol Reprod,2001,64:1285-1296.
7[7]Sounni NE,Devy L,Hajitou A,et al.MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression[J].FASEB J,2002,16(6):555-564.
8[8]Lois A,Salamonsen LA.Current concepts of the mechanisms of menstruation:A normal process of tissue destruction[J].Trends Endocrinol Metab,1998,9(8):305-309.
9[9]Goffin F,Frankenne F,Beliard A,et al.Human endometrial epithelial cells modulate the activation of gelatinase a by stromal cells[J].Gynecol Obstet Invest,2002,53(2):105-111.
10[10]Mizumoto H,Saito T,Ashihara K,et al.Expression of matrix metalloproteinases in ovarian endometriomas:immunohistochemical study and enzyme immunoassay[J].Life Sci,2002,71(3):259-273.
